Bone Biologics Corporation (BBLG) Income Annual - Discounting Cash Flows
BBLG
Bone Biologics Corporation
BBLG (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
10-31
2012
10-31
2011
10-31
2010
10-31
2009
10-31
2008
10-31
Report Filing 2026-03-02 2026-03-02 2025-02-26 2024-02-21 2023-03-30 2022-03-15 2021-04-15 2020-03-30 2019-03-29 2018-04-02 2017-03-30 2016-03-28 2015-03-31 2014-02-13 2013-01-29 2012-01-30 2011-01-31 2010-01-29 2009-01-29
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0 0.001 0.004 0.878 0 0 0.003 0.003 0.003 0
Gross Profit 0 0 0 0 0 0 0 -0 -0 -0 -0.001 -0.004 -0.878 0 0 -0.003 -0.003 -0.003 0
Operating Expenses 3.23 3.23 4.22 9.43 3.67 1.1 0.825 2.45 2.79 2.63 20.41 11.99 2.13 0.672 0.005 0.002 0 0 0
Research & Development 1.06 1.06 2.13 6.91 1.58 0.082 0.341 1.1 0.104 -1.19 11.6 3.67 0.624 0.188 0 0 0 0 0
Selling, General and Administrative 2.17 2.17 2.09 2.52 2.09 1.02 0.484 1.35 2.69 3.82 6.25 8.33 1.51 0.484 0 0 0 0 0
Other Operating Expenses 0 0 0 0 0 0 0 -0 0 0 2.56 -0.004 0.001 0 0.005 0.002 0 0 0
Operating Income -3.23 -3.23 -4.22 -9.43 -3.67 -1.1 -0.825 -2.45 -2.79 -2.63 -20.41 -12 -3.01 -0.672 -0.005 -0.005 -0.003 -0.003 0
Net Non-Operating Interest 0.122 0.122 0.056 0.002 -0.732 -0.804 -0.997 -0.976 -1.23 -4.42 -2.62 -1.87 -1.4 0 0 0 0 0 0
Interest Income 0.122 0.122 0.056 0.002 0 0.001 0.001 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense 0 0 0 0 0.732 0.805 0.998 0.976 1.23 4.42 2.62 1.87 1.4 0 0 0 0 0 0
Equity & Other Income/(Expense) 0.004 0.004 0.051 0.477 2.91 0.297 -0.001 0 -0.409 0 2 0 -0.009 -0.409 0 0 0.003 0.003 -0.013
Income Before Tax -3.11 -3.11 -4.11 -8.95 -1.48 -1.61 -1.82 -3.42 -4.43 -7.05 -21.03 -13.87 -4.42 -1.08 -0.005 -0.005 0 0 -0.013
Income Tax Expense 0 0 0 0 0 0 0.002 0.002 0.002 0.002 0.002 0.009 0.002 0.001 0 0 0 0 0
Income Attributable to Non-Controlling Interest 0 0 -0 0 0 0 0 0 -0.001 0 4.85 0 -0.001 -0 -0.005 -0.005 0 0 0
Net Income -3.11 -3.11 -4.11 -8.95 -1.48 -1.61 -1.82 -3.42 -4.43 -7.05 -25.88 -13.88 -4.42 -1.08 -0.001 0 0 0 -0.013
Depreciation and Amortization 0 0 4.22 9.43 0 0 0 0 0 0 0.001 0.004 0 0.672 0 0 0 0 0
EBITDA -3.23 -3.23 0 0 -3.67 -1.1 -0.825 -2.45 -2.79 -2.63 -20.41 -11.99 -3.01 -0 -0.005 -0.005 -0.003 -0.003 0
Earnings Per Share (EPS) -2.65 -2.65 -4.83 -34.01 -31.15 -37.35 -35.68 -66.97 -3,174 -6,480 -24,840 -17,640 -10,800 0 -49.11 -0.01 0 0 -0.003
Diluted Earnings Per Share -2.65 -2.65 -4.83 -34.01 -31.2 -37.35 -35.68 -66.97 -3,174 -6,480 -24,840 -17,640 -10,800 -37.48 -49.11 -35.42 0 0 -0.003
Weighted Average Shares Outstanding 1.17 1.17 1.52 0.263 0.048 0.043 0.051 0.051 0.001 0.001 0.001 0.001 0 0 5 5 5 5 5
Diluted Weighted Average Shares Outstanding 1.17 1.17 1.52 0.263 0.048 0.043 0.051 0.051 0.001 0.001 0.001 0.001 0 5 5 5 5 5 5
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program